Cargando...
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
CRISPR-Cas9 genome editing technology holds great promise for discovering therapeutic targets in cancer and other diseases. Current screening strategies target CRISPR-induced mutations to the 5’ exons of candidate genes(1–5), but this approach often produces in-frame variants that retain functionali...
Gardado en:
| Publicado en: | Nat Biotechnol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529991/ https://ncbi.nlm.nih.gov/pubmed/25961408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.3235 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|